电磁导航支气管镜诊断肺癌的敏感性与安全性:系统综述与荟萃分析
结果显示ENB诊断恶性肿瘤的合并敏感性为77%(95%CI 72%-82%),特异性100%(95%CI 99%-100%),获取足够样本行辅助检测的比例为90.9%(95%CI 84.8%-96.9%),气胸风险2.0%(95%CI 1.0-3.0)。结论认为ENB安全性高且敏感性良好,但研究间异质性高且多使用superDimension系统。
要点
- ENB诊断周围型肺病变恶性的合并敏感性77%,特异性100%。
- ENB获取足够样本行辅助检测的比例为90.9%,气胸风险仅2.0%。
- 敏感性受传感器尖端至结节中心平均距离、取样技术数量及癌症患病率影响。
核心结论
- ENB对疑似肺癌的周围型肺病变诊断敏感性良好且非常安全。
研究设计与样本
- 全面检索多个数据库,采用QUADAS-2工具评估研究质量,双变量模型进行荟萃分析,并构建sROC曲线,使用GRADE评级证据质量。
主要发现
- ENB诊断恶性肿瘤的合并敏感性为77%(95%CI 72%-82%;I2=80.6%),特异性为100%(95%CI 99%-100%;I2=0%)。
- sROC曲线下面积为0.955(P=.03)。
- ENB获取足够样本行辅助检测的比例为90.9%(95%CI 84.8%-96.9%;I2=80.7%)。
- 气胸风险为2.0%(95%CI 1.0-3.0;I2=45.2%)。
- 亚组分析发现根据偏倚风险和取样技术数量存在差异;Meta回归显示敏感性与此传感器尖端至结节中心平均距离、组织取样技术数量及研究癌症患病率相关。
临床怎么用
- 对于疑似肺癌的周围型肺病变,ENB可作为获取组织诊断的安全手段,敏感性良好且气胸风险低。
- ENB获取的样本在90.9%的情况下足以进行辅助检测,支持后续分子检测等需求。
- 临床决策时应考虑病灶距离、取样技术数量及人群癌症患病率对敏感性的影响。
局限性
- 大多数研究使用superDimension导航系统,限制了研究结果的普适性。
- 研究间异质性高(敏感性I2=80.6%,样本足够率I2=80.7%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bronchoscopy is a useful tool for the diagnosis of lesions near central airways; however, the diagnostic accuracy of these procedures for peripheral pulmonary lesions (PPLs) is a matter of ongoing debate. In this setting, electromagnetic navigation bronchoscopy (ENB) is a technique used to navigate and obtain samples from these lesions. This systematic review and meta-analysis aims to explore the sensitivity of ENB in patients with PPLs suspected of lung cancer. RESEARCH QUESTION: In patients with peripheral pulmonary lesion suspected of lung cancer, what is the sensitivity and safety of electromagnetic navigation bronchoscopy compared to surgery or longitudinal follow up? STUDY DESIGN AND METHODS: A comprehensive search of several databases was performed. Extracted data included sensitivity of ENB for malignancy, adequacy of the tissue sample, and complications. The study quality was assessed using the QUADAS-2 tool, and the combined data were meta-analyzed using a bivariate method model. A summary receiver operatic characteristic curve (sROC) was created. Finally, the quality of evidence was rated using the Grading of Recommendations Assessment, Development and Evaluation approach. RESULTS: Forty studies with a total of 3,342 participants were included in our analysis. ENB reported a pooled sensitivity of 77% (95% CI, 72%-82%; I2 = 80.6%) and a specificity of 100% (95% CI, 99%-100%; I2 = 0%) for malignancy. The sROC showed an area under the curve of 0.955 (P = .03). ENB achieved a sufficient sample for ancillary tests in 90.9% (95% CI, 84.8%-96.9%; I2 = 80.7%). Risk of pneumothorax was 2.0% (95% CI, 1.0-3.0; I2 = 45.2%). We found subgroup differences according to the risk of bias and the number of sampling techniques. Meta-regression showed an association between sensitivity and the mean distance of the sensor tip to the center of the nodule, the number of tissue sampling techniques, and the cancer prevalence in the study. INTERPRETATION: ENB is very safe with good sensitivity for diagnosing malignancy in patients with PPLs. The applicability of our findings is limited because most studies were done with the superDimension navigation system and heterogeneity was high. TRIAL REGISTRY: PROSPERO; No.: CRD42019109449; URL: https://www.crd.york.ac.uk/prospero/.
引用
- Folch EE, Labarca G, Ospina-Delgado D, et al. Sensitivity and Safety of Electromagnetic Navigation Bronchoscopy for Lung Cancer Diagnosis: Systematic Review and Meta-analysis. Chest. 2020. PMID: 32450240. doi:10.1016/j.chest.2020.05.534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。